Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,094.71
(
-0.44%
)
US TECH 100
25,766.38
(
-0.72%
)
Dow Jones
49,329.13
(
-0.24%
)
Brent Oil
92.04
(
-0.67%
)
Bitcoin
74,970.44
(
1.50%
)
News Focus
News Focus
Post# of 257428
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122877
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 204894

Monday, 03/13/2017 8:03:37 PM

Monday, March 13, 2017 8:03:37 PM

Post# of 257428
ARLZ -30% on soft 4Q16 results/2017 guidance:

http://finance.yahoo.com/news/aralez-reports-fourth-quarter-full-103000069.html

ARLZ’s business plan appears involves acquiring unwanted assets from Big Pharma (e.g. #msg-125563785, #msg-125008718).

The company is the result of a reverse merger announced in 2015 (#msg-114404029) and consummated in 2016 (#msg-120344781).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today